Pre-clinical data supports ECRIs' broad-spectrum attack on the IgE axis, distinct from conventional anti-IgE therapies, ...

Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of ...

Basophils have long been suspected to be potent inducers of T helper type 2 differentiation. Sokol and colleagues now demonstrate that basophils are required for adoption of the T helper type 2 fate ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic ...

Are you preparing for UPSC CSE Prelims 2026? Check your progress and revise your topics through this quiz on Science and ...

白细胞介素（IL-4，Interleukin-4）是免疫系统中的一种重要调节因子，它参与感染、过敏、自身免疫和癌症等多种免疫反应。而重组IL-4（重组白介素4，AbMole，M10465）为免疫细胞的培养和分化诱导，以及细胞和动物实验提供了重要工具。

Rhapsido is the first and only Bruton’s tyrosine kinase (BTK) inhibitor approved for chronic spontaneous urticaria (CSU).

Novartis gains FDA approval for Rhapsido, the first oral BTK inhibitor for Chronic Spontaneous Urticaria, offering new hope ...

Novartis’ immunoglobulin E inhibitor Xolair has been a mainstay of treatment for chronic spontaneous urticaria (CSU) for many years, but the company says it has gone one better with new candidate ...

An estimated 3–10% of patients with asthma are unable to reach full control with currently available inhaled therapies. In a ...

Granulocytes are cells of the innate immune system that are characterized by granules in their cytoplasm. The three main types of granulocytes are neutrophils, eosinophils and basophils. Anti-cancer ...